Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review

PLoS Medicine

Volumn 9, Issue 12, 2012, Pages

  Cobelens, Frank ^a,b   van Kampen, Sanne ^b,c   Ochodo, Eleanor ^a,b   Atun, Rifat ^d   Lienhardt, Christian ^e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; ELECTRONIC MEDICAL RECORD; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; REFERENCE DATABASE; SCIENTIFIC LITERATURE; SCORING SYSTEM; SEARCH ENGINE; SYSTEMATIC REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ALGORITHMS; ANTITUBERCULAR AGENTS; COINFECTION; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HIV INFECTIONS; HUMANS; ISONIAZID; PROGRAM DEVELOPMENT; TUBERCULOSIS, PULMONARY;

EID: 84871667102     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001358     Document Type: Article

References (66)

1. (2010) Global tuberculosis control: A short update to the 2009 report. Geneva: World Health Organization.
2. Stop TB Partnership, World Health Organization (2010) The Global Plan to Stop TB, 2011-2015. Geneva: World Health Organization.
3. Lienhardt C, Cobelens FGJ, (2011) Operational research for improved tuberculosis control: the scope, the needs and the way forward. Int J Tuberc Lung Dis 15: 6-13.
4. Schünemann HJ, Schünemann AHJ, Oxman AD, Brozek J, Glasziou P, et al. (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336: 1106-1110.
5. Last JM (2000) A dictionary of epidemiology. 4th edition. New York: Oxford University Press.
6. Sanders D, Haines A, (2006) Implementation research is needed to achieve international health goals. PLoS Med 3: e186 doi:10.1371/journal.pmed.0030186.
7. Thiam S, LeFevre AM, Hane F, Ndiaye A, Ba F, et al. (2007) Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA 297: 380-386.
8. Pai M, Minion J, Steingart K, Ramsay A, (2010) New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 16: 271-284.
9. Mann G, Squire SB, Bissell K, Eliseev P, Du Toit E, et al. (2010) Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Int J Tuberc Lung Dis 14: 1518-1524.
10. Vassall A, Compernolle P, (2006) Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health Policy 79: 1-15.
11. Tuberculosis (z.d.). Available: http://www.stoptb.org/global/plan/main/default.asp. Accessed 2 Nov 2010.
12. Onozaki I, Raviglione M, (2010) Stopping tuberculosis in the 21st century: goals and strategies. Respirology 15: 32-43.
13. Stop TB Partnership: TB/HIV working group (2003) Guidelines for implementing collaborative TB and HIV programme activities. Geneva: World Health Organization.
14. World Health Organization (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization.
15. WHO (2003) Treatment of tuberculosis: Guidelines for national programmes. 3rd edition. Geneva: World Health Organization.
16. WHO (2007) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. Geneva: World Health Organization.
17. WHO (2000) Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization.
18. Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, et al. (2010) The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS 24 Suppl 5: S49-56.
19. Grant AD, Coetzee L, Fielding KL, Lewis JJ, Ntshele S, et al. (2010) "Team up against TB": promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS 24 Suppl 5: S37-44.
20. Mello FC de Q, Bastos LG do V, Soares SLM, Rezende VMC, Conde MB, et al. (2006) Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study. BMC Public Health 6: 43.
21. Lambert ML, Sugulle H, Seyoum D, Abdurahman S, Abdinasir A, et al. (2003) How can detection of infectious tuberculosis be improved? Experience in the Somali region of Ethiopia. Int J Tuberc Lung Dis 7: 485-488.
22. World Health Organization (2007) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents Recommendations for HIV-prevalent and resource-constrained settings. Geneva: World Health Organization.
23. Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, et al. (2011) Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis 11: 533-540.
24. Walley J, Kunutsor S, Evans M, Thoulass J, Katabira E, et al. (2011) Validation in Uganda of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings. J Acquir Immune Defic Syndr 57: e93-100.
25. Soto A, Solari L, Gotuzzo E, Acinelli R, Vargas D, et al. (2011) Performance of an algorithm based on WHO recommendations for the diagnosis of smear-negative pulmonary tuberculosis in patients without HIV infection. Trop Med Int Health 16: 424-430.
26. Koole O, Thai S, Khun KE, Pe R, van Griensven J, et al. (2011) Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults. PLoS ONE 6: e18502 doi:10.1371/journal.pone.0018502.
27. Wilson D, Mbhele L, Badri M, Morroni C, Nachega J, et al. (2011) Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis. Int J Tuberc Lung Dis 15: 919-924.
28. Nguyen DTM, Hung NQ, Giang LT, Dung NH, Lan NTN, et al. (2011) Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis 15: 1528-1534.
29. Van Deun A, Maug AKJ, Salim MAH, Das PK, Sarker MR, et al. (2010) Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 182: 684-692.
30. Loveday M, Wallengren K, Voce A, Margot B, Reddy T, et al. (2012) Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 16: 209-215.
31. Leimane V, Dravniece G, Riekstina V, Sture I, Kammerer S, et al. (2010) Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur. Respir J 36: 584-593.
32. Podewils LJ, Holtz T, Riekstina V, Skripconoka V, Zarovska E, et al. (2011) Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 139: 113-120.
33. Clark PM, Karagoz T, Apikoglu-Rabus S, Izzettin FV, (2007) Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm 64: 497-505.
34. Kunawararak P, Pongpanich S, Chantawong S, Pokaew P, Traisathit P, et al. (2011) Tuberculosis treatment with mobile-phone medication reminders in northern Thailand. Southeast Asian J Trop Med Public Health 42: 1444-1451.
35. Quelapio MID, Mira NRC, Orillaza-Chi RB, Belen V, Muñez N, et al. (2010) Responding to the multidrug-resistant tuberculosis crisis: mainstreaming programmatic management to the Philippine National Tuberculosis Programme. Int J Tuberc Lung Dis 14: 751-757.
36. Heller T, Lessells RJ, Wallrauch CG, Bärnighausen T, Cooke GS, et al. (2010) Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 14: 420-426.
37. Acha J, Sweetland A, Guerra D, Chalco K, Castillo H, et al. (2007) Psychosocial support groups for patients with multidrug-resistant tuberculosis: five years of experience. Glob Public Health 2: 404-417.
38. Bonnet M, Pardini M, Meacci F, Orrù G, Yesilkaya H, et al. (2011) Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection. PLoS ONE 6: e23081 doi:10.1371/journal.pone.0023081.
39. Smith PG, Morrow RH (1991) Methods for field trials of interventions against tropical diseases: A toolbox. New York: Oxford University Press.d
40. Murray DM (1998) Design and analysis of group-randomized trials. 1st edition. New York: Oxford University Press.
41. The Gambia Hepatitis Study Group (1987) The Gambia Hepatitis Intervention Study. Cancer Res 47: 5782-5787.
42. Hussey MA, Hughes JP, (2007) Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 28: 182-191.
43. Brown CA, Lilford RJ, (2006) The stepped wedge trial design: a systematic review. BMC Med Res Methodol 6: 54.
44. Squire SB, Ramsay ARC, van den Hof S, Millington KA, Langley I, et al. (2011) Making innovations accessible to the poor through implementation research. Int J Tuberc Lung Dis 15: 862-870.
45. Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, et al. (2004) Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J. Tuberc Lung Dis 8: 1382-1384.
46. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, et al. (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerging Infect Dis 12: 1389-1397.
47. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, et al. (2008) Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3: e3081 doi:10.1371/journal.pone.0003081.
48. Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, et al. (2010) Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS 24 Suppl 5: S57-65.
49. Leung CC, Rieder HL, Lange C, Yew WW, (2011) Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 37: 690-711.
50. Getahun H, Harrington M, O'Brien R, Nunn P, (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
51. Cobelens FGJ, Heldal E, Kimerling ME, Mitnick CD, Podewils LJ, et al. (2008) Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med 5: e150 doi:10.1371/journal.pmed.0050150.
52. Mount FW, Ferebee SH, (1961) Preventive effects of isoniazid in the treatment of primary tuberculosis in children. N Engl J Med 265: 713-721.
53. Ferebee SH, Mount FW, (1962) Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am. Rev Respir Dis 85: 490-510.
54. Egsmose T, Ang'awa JO, Poti SJ, (1965) The use of isoniazid among household contacts of open cases of pulmonary tuberculosis. Bull World Health Organ 33: 419-433.
55. Del Castillo H, Bautista L, Jacinto C, Lorenzo C, Lapuz S, et al. (1965) Chemoprophylaxis in the Philippines. A controlled pilot study among household contacts of tuberculosis cases. Bull Quezon Institute 7: 277-290.
56. Comstock GW, Ferebee SH, Hammes LM, (1967) A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 95: 935-943.
57. Kochi A, (1997) Tuberculosis control-is DOTS the health breakthrough of the 1990s? World Health Forum 18: 225-232.
58. Stop TB Partnership (2011) An international roadmap for tuberculosis research. Geneva: World Health Organization. Available: www.stoptb.org/assets/.
59. Stop TB Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria (2011) Priorities in operational research to improve tuberculosis care and control. Geneva: World Health Organization.
60. Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, et al. (2010) Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 375: 2179-2191.
61. World Health Organization (2011) Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: Policy statement.WHO/HTM/TB/2011.18. Available: http://www.who.int/tb/publications/2011/en/index.html. Geneva: World Health Organization.
62. WHO (2006) WHO Report 2006. Tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization.
63. (2008) Anti-tuberculosis drug resistance in the world. Fourth global report. Geneva: World Health Organization.
64. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, et al. (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 62: 464-475.
65. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et al. (2010) An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 362: 707-716.
66. Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Nguyen HD, et al. (2009) Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 180: 903-908.